PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM‐398) or irinotecan with leucovorin/5‐fluorouracil as second‐line therapy in metastatic colorectal cancer

A multicenter, open‐label, noncomparative, randomized phase II study (PEPCOL) was conducted to evaluate the efficacy and safety of the irinotecan or PEP02 (MM‐398, nanoliposomal irinotecan) with leucovorin (LV)/5‐fluorouracil (5‐FU) combination as second‐line treatment in patients with metastatic co...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Med
Hoofdauteurs: Chibaudel, Benoist, Maindrault‐Gœbel, Frédérique, Bachet, Jean‐Baptiste, Louvet, Christophe, Khalil, Ahmed, Dupuis, Olivier, Hammel, Pascal, Garcia, Marie‐Line, Bennamoun, Mostefa, Brusquant, David, Tournigand, Christophe, André, Thierry, Arbaud, Claire, Larsen, Annette K, Wang, Yi‐Wen, Yeh, C. Grace, Bonnetain, Franck, de Gramont, Aimery
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2016
Onderwerpen:
Cancer Biology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4831286/
https://ncbi.nlm.nih.gov/pubmed/26806397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.635
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items